The FDA Orange Book, or Approved Drug Products with Therapeutic Equivalence Evaluations, is the definitive source to link drugs with the patents that protect them. Over the years we’ve had…
The post Free Orange Book PDF Library from DrugPatentWatch app…
Free Orange Book PDF Library from DrugPatentWatch Read Post »
This article was originally published by Syed Sauban Ghani in Eclética Química under a Creative Commons license. ABSTRACT As scientific community worldwide is publishing a huge number of research articles…
The post A comprehensive review of database re…
A comprehensive review of database resources in chemistry Read Post »
This article was originally published by Mohammed M. Alshehri and Mahmoud M. E. Mudawi in the Journal of Pharmaceutical Research International under the terms of the Creative Commons Attribution License.…
The post Common Drugs with Effective Off-Label …
Check out this Bloomberg Law article where DrugPatentWatch shows how the number of patent challenges is increasing, while the number of challengers of each patent is also increasing. Why might this…
The post DrugPatentWatch and Bloomberg: Are there too…
DrugPatentWatch and Bloomberg: Are there too many generic patent challenges? Read Post »
In response to customer requests, we’ve built some new tools for formulary management. You can preview these tools at: Recent Generic Drug Launches Upcoming 180-Day Patent Challenge Exclusivity Expirations Anticipate…
The post Customer Success: Formula…
Let DrugPatentWatch build custom dashboards and reports to take the load off of your team. We can ensure the production of accurate, objective, and timely intelligence to help you quickly…
The post Automated Reports and Custom Dashboards appeared first…
This article was originally published by Hermann Mucke & Peter Mucke in Future Drug Discovery under a Attribution-NonCommercial-NoDerivatives 4.0 Unported License. https://doi.org/10.4155/fdd-2020-0001. Drug developers require access to scientific info…
In a recent court ruling, the U.S. Court of Appeals for the Federal Circuit (CAFC) denied a petition to rehear arguments regarding the invalidity of patent claims containing the phrase…
The post 244 Drug Patents With Claims Containing “consisting essen…
244 Drug Patents With Claims Containing “consisting essentially of” may be Unenforceable Read Post »
One of our clients, the Belarus Republican Scientific and Technical Library recently posted an article on how they support innovation. They open with the statement that “The novelty, effectiveness and…
The post Customer Success: DrugPatentWatch for You…
Customer Success: DrugPatentWatch for Your Library Read Post »
This is a guest post from Susan K Finston, President of Finston Consulting. Do you have a response to Susan’s
Biotechnology in Countries Starting with “I” – Part 13: Israel Read Post »